<VariationArchive VariationID="541718" VariationName="NM_000018.4(ACADVL):c.104del (p.Pro35fs)" VariationType="Deletion" Accession="VCV000541718" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-14" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="531746" VariationID="541718">
      <GeneList>
        <Gene Symbol="ACADVL" FullName="acyl-CoA dehydrogenase very long chain" GeneID="37" HGNC_ID="HGNC:92" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7217125" stop="7225266" display_start="7217125" display_stop="7225266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7120443" stop="7128585" display_start="7120443" display_stop="7128585" Strand="+" />
          </Location>
          <OMIM>609575</OMIM>
        </Gene>
        <Gene Symbol="LOC130060113" FullName="ATAC-STARR-seq lymphoblastoid silent region 8088" GeneID="130060113" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7220062" stop="7220271" display_start="7220062" display_stop="7220271" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000018.4(ACADVL):c.104del (p.Pro35fs)</Name>
      <CanonicalSPDI>NC_000017.11:7220160:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7220161" stop="7220161" display_start="7220161" display_stop="7220161" variantLength="1" positionVCF="7220160" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7123480" stop="7123480" display_start="7123480" display_stop="7123480" variantLength="1" positionVCF="7123479" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_000018.4(ACADVL):c.104del</Name>
        <Name>p.Pro35fs</Name>
      </OtherNameList>
      <ProteinChange>P35fs</ProteinChange>
      <ProteinChange>P58fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7123482del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7123482del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7220163del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7220163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007975.1" sequenceAccession="NG_007975" sequenceVersion="1" change="g.5330del">
            <Expression>NG_007975.1:g.5330del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008391.2" sequenceAccession="NG_008391" sequenceVersion="2" change="g.4890del">
            <Expression>NG_008391.2:g.4890del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.104del" MANESelect="true">
            <Expression>NM_000018.4:c.104del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000009.1" sequenceAccession="NP_000009" sequenceVersion="1" change="p.Pro35fs">
            <Expression>NP_000009.1:p.Pro35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001033859.3" sequenceAccession="NM_001033859" sequenceVersion="3" change="c.104del">
            <Expression>NM_001033859.3:c.104del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001029031.1" sequenceAccession="NP_001029031" sequenceVersion="1" change="p.Pro35fs">
            <Expression>NP_001029031.1:p.Pro35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270447.2" sequenceAccession="NM_001270447" sequenceVersion="2" change="c.173del">
            <Expression>NM_001270447.2:c.173del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257376.1" sequenceAccession="NP_001257376" sequenceVersion="1" change="p.Pro58fs">
            <Expression>NP_001257376.1:p.Pro58fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270448.2" sequenceAccession="NM_001270448" sequenceVersion="2" change="c.-125del">
            <Expression>NM_001270448.2:c.-125del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA624861220" DB="ClinGen" />
        <XRef Type="rs" ID="1443151475" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000018.4(ACADVL):c.104del (p.Pro35fs) AND Very long chain acyl-CoA dehydrogenase deficiency" Accession="RCV000652036" Version="10">
        <ClassifiedConditionList TraitSetID="417">
          <ClassifiedCondition DB="MedGen" ID="C3887523">Very long chain acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-04-06" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-06" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-05-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11590124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25834949</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32276429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9973285</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/d4bf1068-23a1-499a-842b-683684db2c60</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="27" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Very long chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="VLCAD+deficiency/7410" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008723" DB="MONDO" />
                <XRef ID="237997005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VLCAD deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VLCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCADD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACADVLD</ElementValue>
                <XRef Type="MIM" ID="201475" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5508" />
                <XRef ID="5508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of very long-chain acyl-coenzyme A dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</Attribute>
                <XRef ID="NBK6816" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301763</ID>
                <ID Source="BookShelf">NBK6816</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/130/VLCAD%20Nutrition%20Guidelines/Version%201.1</URL>
                <CitationText>VLCAD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C14.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C14:1 +/- other long-chain acylcarnitines, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="26793" DB="Orphanet" />
              <XRef ID="C3887523" DB="MedGen" />
              <XRef ID="MONDO:0008723" DB="MONDO" />
              <XRef Type="MIM" ID="201475" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2704082" SubmissionDate="2020-07-13" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="NM_000018.3:c.104delC|OMIM:201475" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001364883" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="2" SubmitterName="Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine" OrgID="506302" OrganizationCategory="laboratory" OrgAbbreviation="WongLab-BCM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25834949</ID>
          </Citation>
          <Comment>The NM_000018.3:c.104delC (NP_000009.1:p.Pro35LeufsTer26) [GRCH38: NC_000017.11:g.7220163delC] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID: 25834949 . This variant meets the following evidence codes reported in the ACMG guidelines: PVS1, PS3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.3:c.104delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7761254</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3195327" SubmissionDate="2021-05-19" DateLastUpdated="2021-05-23" DateCreated="2021-05-23">
        <ClinVarSubmissionID localKey="NM_000018.3:c.104delC|MedGen:C3887523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001623415" DateUpdated="2021-05-23" DateCreated="2021-05-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9973285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32276429</ID>
          </Citation>
          <Comment>Variant summary: ACADVL c.104delC (p.Pro35LeufsX26) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2.2e-05 in 137290 control chromosomes. c.104delC has been reported in the literature in multiple individuals affected with Very Long Chain Acyl-CoA Dehydrogenase Deficiency (Andresen_1999, Knottnerus_2020). These data indicate that the variant is very likely to be associated with disease. At least one publication reports that enzyme activity in the patient carrying homozygous c.104delC had &lt;10% of normal activity (Knottnerus_2020). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.3:c.104delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9683184</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="4966760" SubmissionDate="2023-03-31" DateLastUpdated="2023-04-15" DateCreated="2022-07-02">
        <ClinVarSubmissionID localKey="d4bf1068-23a1-499a-842b-683684db2c60" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002538677" DateUpdated="2023-04-15" DateCreated="2022-07-02" Type="SCV" Version="2" SubmitterName="ClinGen ACADVL Variant Curation Expert Panel, ClinGen" OrgID="508473" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-06">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/d4bf1068-23a1-499a-842b-683684db2c60</URL>
          </Citation>
          <Comment>The c.104del (p.(Pro35Leufs*26)) (NM_000018.4) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 2/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs: 9973285, 11590124). This variant has been detected in at least 4 individuals with VLCADD. Of those individuals, 1 was compound heterozygous for the variant and a pathogenic or likely pathogenic variant and was not confirmed in trans (PM3 0.5 pt, PMID: 25834949). 3 individuals were homozygous for the variant (PM3 1.0 point max., PMIDs: 25834949, 32276429) (PM3). The highest population minor allele frequency in gnomAD v2.1.1 is 0.007886%(2/25360 alleles) in AMR population, which is lower than the ClinGen ACADVL VCEP threshold (&lt;0.1%) for PM2_Supporting, meeting this criterion (PM2_Supporting). To our knowledge, functional assays have not been reported for this variant. To our knowledge, this variant has not been reported in the literature for segregation in family members affected with VLCADD. In summary, this variant has been classified as pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Curation Expert Panel: PVS1, PM3, PP4_Moderate, PM2_Supporting (ACADVL VCEP specifications v2.0; Approved on 10/11/2021).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">clingen acadvl acmg specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/iz6xgwit/clingen_acadvl_acmg_specifications_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000018.4(ACADVL):c.104del</Name>
            <Name>p.Pro35fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.7220163del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008723" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11489972</SubmissionName>
          <SubmissionName>SUB13008499</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1483661" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2635416|MedGen:C3887523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000773897" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9973285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11590124</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9973285</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25834949</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro35Leufs*26) in the ACADVL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADVL are known to be pathogenic (PMID: 9973285, 11590124). This variant is present in population databases (no rsID available, gnomAD 0.008%). This premature translational stop signal has been observed in individuals with very long chain acyl-CoA dehydrogenase deficiency (PMID: 9973285, 25834949). ClinVar contains an entry for this variant (Variation ID: 541718). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7123480del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1483661" TraitType="Disease" MappingType="XRef" MappingValue="C3887523" MappingRef="MedGen">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3195327" TraitType="Disease" MappingType="XRef" MappingValue="C3887523" MappingRef="MedGen">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2704082" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4966760" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008723" MappingRef="MONDO">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

